1. Beyond cyclopamine: Targeting Hedgehog signaling for cancer intervention
   Beena Thazhackavayal Baby et al, 2024, Archives of Biochemistry and Biophysics CrossRef
2. CDK4/6 Inhibitors—Overcoming Endocrine Resistance Is the Standard in Patients with Hormone Receptor-Positive Breast Cancer
   Naiba Nabieva et al, 2023, Cancers CrossRef
3. Therapeutic vulnerabilities in triple negative breast cancer: Stem-like traits explored within molecular classification
   Peng Huang et al, 2024, Biomedicine & Pharmacotherapy CrossRef
4. Unraveling the dangerous duet between cancer cell plasticity and drug resistance
   Namrata Chatterjee et al, 2023, Computational and Systems Oncology CrossRef
5. Dysregulated FOXM1 signaling in the regulation of cancer stem cells
   Gulab Sher et al, 2022, Seminars in Cancer Biology CrossRef
6. OTUD7B knockdown inhibits the proliferation and stemness of breast cancer cells by destabilizing FOXM1
   Hebing Wang et al, 2024, Oncology Letters CrossRef
7. Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
   Khubaib Ali et al, 2024, Medical Oncology CrossRef
8. RNA methylation and cellular response to oxidative stress-promoting anticancer agents
   Marco Ponzetti et al, 2023, Cell Cycle CrossRef